Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: aspirin attending: chief complaint: # sdh/sah fall # facial fractures fall major surgical or invasive procedure: none history of present illness: 72m h/o htn, alzheimer??????s dementia, admitted initially by trauma surgery to sicu s/p fall down stairs onto concrete with loc and witnessed seizure-like episode. pt sustained multiple facial fractures, small r front sah, and significant epistaxis. . ed: # vs: t unmeasured, bp 140/80, hr 102, rr 24, sao2 96/ra # intervention: intubated given epistaxis # notable studies --ct head: r frontal subdural, subarachnoid hemorrhage. r temporal subarachnoid hemorrhage. b inferior temporal lobe hemorrhagic contusions. no midline shift. --ct cervical spine: no fracture. # transferred to trauma sicu # consults --plastics: no intervention recommended --neurosurgery: no acute issues . after initial admission, pt had increased delirium requiring 1:1 sitter. pt also developed hypernatremia, and was transferred to medicine for management of hypernatremia and delirium. past medical history: # htn # hyperlipidemia # alzheimer's dementia # prostate ca # b glaucoma # b cataracts # chronic back pain # gerd social history: # personal: lives with wife in son's home # professional: retired school custodian # tobacco: never # alcohol: never # recreational drugs: never family history: pt was adopted and does not know his biological fh. physical exam: vs: tm 99.8, tc 99.8, bp 147/98 (124-147/72-98), hr 97-101, rr 16-18, sao2 94/ra - 98/ra, fs 133 i 340 po + 1200 ivf / o 1900 . gen: nad, sleeping heent: b raccoon ecchymosis under eyes cv: rrr, s1s2, no m/r/g appreciated chest: ctab although pt difficult to position. abd: soft, ntnd, mildly tympanic, hypoactive bs ext: moving all extremities spontaneously, no c/c/e noted at ble. pertinent results: notable admission labs: . 12:40am wbc-11.0 rbc-4.85 hgb-15.9 hct-42.4 mcv-88 mch-32.7* mchc-37.4* rdw-13.3 12:40am urea n-30* creat-1.1 12:53am glucose-148* lactate-2.4* na+-139 k+-3.3* cl--97* tco2-26 12:13pm phenytoin-8.3* 12:13pm ck-mb-10 mb indx-0.9 ctropnt-<0.01 08:55am blood wbc-10.7 rbc-3.46* hgb-11.5* hct-32.6* mcv-94 mch-33.3* mchc-35.4* rdw-14.5 plt ct-181 08:55am blood glucose-117* urean-15 creat-0.7 na-144 k-3.7 cl-109* hco3-24 angap-15 02:41am blood calcium-8.5 phos-2.3* mg-2.1 . notable studies: . # ct sinus/mandible/maxillofacial w/o contrast 2:14 pm impression: multiple fractures as described above involving both orbits, the right temporal bone, and the sphenoid bone with several fracture clefts extending intracranially as described above. . # ct head w/o contrast 2:14 pm impression: since approximately 13 hours prior, there is increase in extent of subarachnoid hemorrhages. newly visible are hemorrhagic contusions of the inferior temporal lobes bilaterally. there is new intraventricular blood within the lateral and fourth ventricles. no significant change in the subdural hematomas over the right frontal and temporal lobes as well as layering along the tentorium. cxr findings: recently described left retrocardiac opacity has slightly improved and may be due to an area of resolving aspiration. lateral chest radiograph is technically nondiagnostic due to low lung volumes and respiratory motion. allowing for this limitation, lungs are otherwise grossly clear and there are no pleural effusions. impression: improving left retrocardiac opacity, likely due to resolving area of aspiration or atelectasis. head ct findings: since the prior study, there has been evolution of both the right frontal epidural hemorrhage, which is less evident than on the prior study, adjacent to the nondisplaced right frontal and temporal bone fracture. there has also been evolution of the bilateral extensive subarachnoid blood, which is not now as evident as it was on the prior study. no new hemorrhage is identified. the ventricular size in the temporal horns of the lateral ventricle, the frontal horns, as well as the third ventricle appears slightly larger than on the prior study, for example, the third ventricular diameter previously measured 6 mm and now measures 8 mm, and at roughly the same level, the diameter of the frontal of the left lateral ventricle measures 10 mm where before it measured 8 mm. there is no change in the size of the fourth ventricle. a small subdural hemorrhage tracking along the anterior convexity on the left is likely, and also appears to have evolved since the prior study. hypodensity of the left temporal lobe is seen, consistent with contusion. small hypodensities of the left basal ganglia region and the periventricular white matter are noted, which likely represent microangiopathic changes. fractures across the lateral orbital walls bilaterally also appears stable. air-fluid levels are noted within the sphenoid air cells with a fracture through the sphenoid bone again noted as well. please refer to the ct of the sinus study done on for full details regarding multiple fractures. impression: 1. evolution of the previously demonstrated subarachnoid, right epidural, probable left subdural blood. no new hemorrhage. 2. apparent mild increase in the size of the lateral ventricles as well as the third ventricle. continued attention in followup is recommended to exclude developing hydrocephalus brief hospital course: 72m h/o htn, alzheimer's dementia, admitted to after falling and sustaining r frontal and temporal sah and sdh, bilateral infratemporal contusions, and extensive facial fractures which did not require intervention. pt's admission complicated by hyperactive delirium. . # delirium: pt's hyperactive delirium likely multifactorial, with contributing factors including pain, hospitalization, sah/sdh, intracranial contusions, and foley catheter. the patient was initially treated with haldol and required a 1:1 sitter for several evenings. his haldol was eventually discontinued and replaced with quetiepine, which the patient has tolerated well. in addition, he has not required a 1:1 sitter in two days. his mental status still fluctuates, being most alert during the day and most somnolent/confused in the evening and early morning. . # sleep/wake cycle: patient's trazodone dose was decreased from 100mg qhs to 50-100mg qhs, for fear that the increased dose could be exacerbating delirium. . # pain control: patient has been receiving acetomenophen 1000mg pr tid for pain control. this was switched to acetomenophen 650mg po q6h with 650mg pr prn in the event that the patient could not tolerate po intake. . # bowel regimen: patient was placed on an aggressive bowel regimen to minimize factors which could exacerbate delirium. senna 2tab po hs, lactulose 30 ml po tid, bisacodyl 10 mg po/pr daily, and docusate 200 mg po bid, all titrated to 1bm daily. . # witnessed seizure: pt's family reported that pt seized around his fall, and this may have contributed to his fall, although pt had not been previously diagnosed with seizures. pt was started on phenytoin 100 mg po tid as inpatient ppx against seizures, given his subdural and subarachnoid hemmorrhages. per neurosurgery reccommendations, the patient's phenytoin was switched to keppra. he was begun on 500mg po bid for two days, and continued on 1000mg po bid for two days, and then 1500mg po bid continuous. he has received two days of 500mg. he will begin keppra 1000mg po bid starting . . # hypernatremia: patient developed hypernatremia secondary to dehydration. the hypernatremia resolved with fluid resuscitation. . # alzheimer's dementia: pt continued on home regimen of exelon *nf* 6 mg po bid. . # hyperglycemia, impaired glucose tolerance: pt's fasting blood glucose had been high during this admission, ranging between 130-190, and pt was therefore covered with humalog insulin sliding scale. the patient should be evaluated by his pcp for further management of impaired glucose tolerance. . # urinary retention: pt had been having difficulty voiding during this admission, and therefore was started on terasozin 3 mg qhs. the subsequently developed hypotension and so his terazosin was discontinued. he will be discharged with a foley in place. this foley should be replaced with a foley catheter with leg bag attachment upon arrival to his extended care facility. he has a follow-up urology appointment scheduled. . # prostate ca: pt continued on home regimen of megestrol 20 mg po bid. . # b glaucoma: pt administered timolol 0.5% 1 drop ou . patient should schedule an ophthalmology appointment in weeks. . # htn: patient's dose of quinapril was decreased to 5mg po qd. . # hyperlipidemia: pt continued on tricor 145 mg po daily and simvastatin 80mg po daily. . medications on admission: # rivastigmine 6mg # hctz 25mg daily # furosemide 40mg po bid # simvastatin 80mg daily # fenofibrate 145mg po daily # megestrol 20mg # pantoprazole 40mg po daily # mvi # vitamin b + c # trazodone 100mg qhs discharge medications: 1. megestrol 40 mg tablet sig: 0.5 tablet po bid (2 times a day). 2. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 3. simvastatin 40 mg tablet sig: two (2) tablet po daily (daily). 4. fenofibrate micronized 145 mg tablet sig: one (1) tablet po daily (). 5. trazodone 50 mg tablet sig: 1-2 tablets po hs (at bedtime). 6. rivastigmine 3 mg capsule sig: two (2) capsule po bid (2 times a day). 7. timolol maleate 0.5 % drops sig: one (1) drop ophthalmic (2 times a day). 8. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily). 9. docusate sodium 100 mg capsule sig: two (2) capsule po bid (2 times a day). 10. quinapril 5 mg tablet sig: one (1) tablet po daily (daily). 11. hexavitamin tablet sig: one (1) cap po daily (daily). 12. acetaminophen 650 mg tablet sig: one (1) tablet po every six (6) hours as needed for pain. 13. acetaminophen 650 mg suppository sig: one (1) suppository rectal q6h:prn as needed for if cannot tolerate po. 14. levetiracetam 500 mg tablet sig: two (2) tablet po bid (2 times a day) for 2 days. 15. levetiracetam 500 mg tablet sig: one (1) tablet po bid (2 times a day) for 1 days. 16. levetiracetam 500 mg tablet sig: three (3) tablet po bid (2 times a day): to start and continue, after patient has received two days of leviracetam 1000mg for two days. 17. senna 8.6 mg tablet sig: one (1) tablet po hs (at bedtime). 18. olanzapine 2.5 mg tablet sig: one (1) tablet po bid (2 times a day). 19. olanzapine 2.5 mg tablet sig: 0.5 tablet po qid (4 times a day) as needed. 20. insulin lispro 100 unit/ml solution sig: two (2) units subcutaneous asdir (as directed). 21. lactulose 10 g/15 ml syrup sig: thirty (30) ml po tid: prn. discharge disposition: extended care facility: northeast - discharge diagnosis: fall facial fractures subdural hematoma subarachnoid hemmorrhage alzhemier's dementia delirium discharge condition: good 97.0 99.1 118/73 98 17 95%ra discharge instructions: you were admitted to the hospital after falling and sustaining multiple facial fractures, along with subdural and subarachnoid bleeding. please return to the hospital if you experience chest pain, shortness of breath, nausea, headache, or light headedness. please follow-up with your pcp . and ask how best to manage your increased blood sugar levels. your extended are facility should replace your current foley catheter with a catheter with a leg attachment. you are scheduled to see a urologist, dr. on followup instructions: please follow-up with patient's ophthalmologist in two weeks. provider: . at 2:00pm provider: , md phone: date/time: 3:30 provider: scan phone: date/time: 8:00 provider: , md phone: date/time: 9:30 procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube diagnoses: esophageal reflux unspecified essential hypertension other convulsions unspecified glaucoma other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus accidental fall on or from other stairs or steps malignant neoplasm of prostate retention of urine, unspecified alzheimer's disease dementia in conditions classified elsewhere without behavioral disturbance dehydration hyperosmolality and/or hypernatremia systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction closed fracture of other facial bones delirium due to conditions classified elsewhere epistaxis unspecified cataract closed fracture of nasal bones closed fracture of base of skull with cerebral laceration and contusion, with brief [less than one hour] loss of consciousness contusion of forearm 

Answer: The patient is high likely exposed to